Pular para o conteúdo
Encefalite
ORPHA:97275CID-10 · A86DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Face / craniofacial
Também conhecida comoEncefalites

Processo inflamatório agudo que afeta o parênquima cerebral. As causas incluem infecções virais e, menos frequentemente, infecções bacterianas, toxinas e processos imunomediados.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A encefalite é uma inflamação aguda do cérebro que pode ser causada por infecções como vírus e bactérias, ou por alterações do próprio sistema de defesa do organismo. A pessoa acometida pode apresentar confusão, agitação, rigidez nos músculos, fraqueza na face, tremores e movimentos anormais. O diagnóstico exige investigação médica rápida, com exames do líquor para identificar o agente causador ou autoanticorpos. No Brasil, a condição não consta na lista de PCDTs oficiais de doenças raras do SUS, sendo o cuidado conduzido pela rede hospitalar do sistema de saúde.

📋
Informacoes curadas por IA — podem conter imprecisoes

Processo inflamatório agudo que afeta o parênquima cerebral. As causas incluem infecções virais e, menos frequentemente, infecções bacterianas, toxinas e processos imunomediados.

Pesquisas ativas
81 ensaios
340 total registrados no ClinicalTrials.gov
Publicações científicas
55.567 artigos
Último publicado: 2026 Mar
Medicamentos
1 com registro
RIBAVIRIN

Tem tratamento?

✓ 1 medicamento específico desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
RIBAVIRIN
Mais 9 moléculas em estudo para esta doença.
🏥
SUS: Cobertura mínimaScore: 0%
CID-10: A86
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
60 sintomas
💪
Músculos
15 sintomas
👁️
Olhos
14 sintomas
🫁
Pulmão
11 sintomas
🛡️
Imunológico
11 sintomas
🫃
Digestivo
10 sintomas

+ 176 sintomas em outras categorias

Características mais comuns

—
Fraqueza da musculatura facial
—
Teratoma testicular
—
Coreia
—
Rigidez
—
Hipotensão ortostática
—
Maneirismos repetitivos anormais
335sintomas
Sem dados (335)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 335 características clínicas mais associadas, ordenadas por frequência.

Fraqueza da musculatura facialWeakness of facial musculature
Teratoma testicularTesticular teratoma
CoreiaChorea
RigidezRigidity
Hipotensão ortostáticaOrthostatic hypotension

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico55.567PubMed
Últimos 10 anos200publicações
Pico2026199 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

7 genes identificados com associação a esta condição.

CPT2Carnitine O-palmitoyltransferase 2, mitochondrialCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Carnitine shuttlePPARA activates gene expression
MECANISMO DE DOENÇA

Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced

An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are exacerbated by prolonged exercise, fasting, cold, or viral infection. CPT2DM affects most frequently children or young adults, and severity of attacks is highly variable. Myoglobinuria can cause kidney failure and death.

OUTRAS DOENÇAS (5)
carnitine palmitoyl transferase II deficiency, neonatal formcarnitine palmitoyl transferase II deficiency, severe infantile formcarnitine palmitoyl transferase II deficiency, myopathic formacute necrotizing encephalopathy of childhood
HGNC:2330UniProt:P23786
RANBP2E3 SUMO-protein ligase RanBP2Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
SUMOylation of DNA replication proteinsSUMOylation of SUMOylation proteins
MECANISMO DE DOENÇA

Encephalopathy, acute, infection-induced, 3

A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
39.9 TPM
Ovário
37.7 TPM
Fibroblastos
36.7 TPM
Pituitária
36.5 TPM
Útero
34.5 TPM
OUTRAS DOENÇAS (3)
familial acute necrotizing encephalopathyacute necrotizing encephalopathy of childhoodinflammatory myofibroblastic tumor
HGNC:9848UniProt:P49792
TBK1Serine/threonine-protein kinase TBK1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
PINK1-PRKN Mediated MitophagyDDX58/IFIH1-mediated induction of interferon-alpha/betaSARS-CoV-2 activates/modulates innate and adaptive immune responsesTRAF3-dependent IRF activation pathwayTRAF6 mediated IRF7 activation
MECANISMO DE DOENÇA

Glaucoma 1, open angle, P

A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. GLC1P is characterized by early onset, thin central corneas and low intraocular pressure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
50.3 TPM
Testículo
42.8 TPM
Fibroblastos
35.0 TPM
Pulmão
30.8 TPM
Útero
30.3 TPM
OUTRAS DOENÇAS (6)
autoinflammation with arthritis and vasculitisfrontotemporal dementia and/or amyotrophic lateral sclerosis 4amyotrophic lateral sclerosisfrontotemporal dementia with motor neuron disease
HGNC:11584UniProt:Q9UHD2
TLR3Toll-like receptor 3Candidate gene tested inTolerante
VIAS BIOLÓGICAS (10)
TICAM1,TRAF6-dependent induction of TAK1 complexToll Like Receptor 3 (TLR3) CascadeRIP-mediated NFkB activation via ZBP1TICAM1, RIP1-mediated IKK complex recruitmentTLR3-mediated TICAM1-dependent programmed cell death
MECANISMO DE DOENÇA

Immunodeficiency 83, susceptibility to viral infections

An immunologic disorder characterized by increased susceptibility to severe viral infections, including herpes simplex virus (HSV), varicella zoster virus (VZV), influenza A virus (IAV), hantavirus, and possibly respiratory syncytial virus (RSV). IMD83 clinical manifestations include acute infection-induced encephalitis and pneumonitis. The susceptibility to encephalitis or pneumonitis appears to result from impaired TLR3-dependent interferon production by nonhematopoietic cells that reside within the central nervous system or lung epithelial cells. IMD83 transmission pattern is consistent with autosomal dominant or autosomal recessive inheritance with incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
5.1 TPM
Vagina
4.1 TPM
Adipose Visceral Omentum
4.1 TPM
Esôfago - Mucosa
4.0 TPM
Glândula adrenal
4.0 TPM
OUTRAS DOENÇAS (3)
herpes simplex encephalitissusceptibility to HIV infectionimmunodeficiency 83, susceptibility to viral infections
HGNC:11849UniProt:O15455
TICAM1TIR domain-containing adapter molecule 1Candidate gene tested inDesconhecido
VIAS BIOLÓGICAS (8)
TICAM1,TRAF6-dependent induction of TAK1 complexToll Like Receptor 3 (TLR3) CascadeRIP-mediated NFkB activation via ZBP1TICAM1, RIP1-mediated IKK complex recruitmentTLR3-mediated TICAM1-dependent programmed cell death
MECANISMO DE DOENÇA

Encephalopathy, acute, infection-induced, 6, herpes-specific

A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
60.9 TPM
Linfócitos
46.6 TPM
Aorta
34.9 TPM
Skin Not Sun Exposed Suprapubic
32.1 TPM
Pulmão
31.5 TPM
OUTRAS DOENÇAS (2)
herpes simplex encephalitisherpes simplex encephalitis, susceptibility to, 4
HGNC:18348UniProt:Q8IUC6
TRAF3TNF receptor-associated factor 3Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (6)
Ovarian tumor domain proteasesNegative regulators of DDX58/IFIH1 signalingActivation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)TICAM1-dependent activation of IRF3/IRF7TNFR2 non-canonical NF-kB pathway
MECANISMO DE DOENÇA

Immunodeficiency 132A

An autosomal dominant immunologic disorder characterized by increased susceptibility to infection with certain pathogens, including Herpes simplex virus and Mycobacterium abscessus. Immunologic work-up shows impaired production of cytokines, including INFB and IL6.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
51.8 TPM
Cérebro - Hemisfério cerebelar
18.3 TPM
Cerebelo
18.0 TPM
Testículo
16.5 TPM
Pituitária
16.3 TPM
OUTRAS DOENÇAS (3)
herpes simplex encephalitis, susceptibility to, 3immunodeficiency 132bherpes simplex encephalitis
HGNC:12033UniProt:Q13114
UNC93B1Protein unc-93 homolog B1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Trafficking and processing of endosomal TLR
MECANISMO DE DOENÇA

Encephalopathy, acute, infection-induced, 1, herpes-specific

A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. It is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
128.5 TPM
Linfócitos
76.4 TPM
Sangue
66.9 TPM
Pulmão
60.4 TPM
Intestino delgado
52.1 TPM
OUTRAS DOENÇAS (2)
herpes simplex encephalitisherpes simplex encephalitis, susceptibility to, 1
HGNC:13481UniProt:Q9H1C4

Medicamentos e terapias

SATRALIZUMABPhase 3

Mecanismo: IL6Ralpha/GP130 antagonist

METHYLPREDNISOLONE SODIUM SUCCINATEPhase 3

Mecanismo: Glucocorticoid receptor agonist

METHYLPREDNISOLONE HEMISUCCINATEPhase 3

Mecanismo: Glucocorticoid receptor agonist

PEMBROLIZUMABPhase 2

Mecanismo: Programmed cell death protein 1 inhibitor

RITUXIMABPhase 2

Mecanismo: B-lymphocyte antigen CD20 binding agent

RIBAVIRINPhase 2

Mecanismo: Inosine-5'-monophosphate dehydrogenase 1 inhibitor

INEBILIZUMABPhase 2

Mecanismo: B-lymphocyte antigen CD19 binding agent

OCRELIZUMABPhase 2

Mecanismo: B-lymphocyte antigen CD20 binding agent

ALDESLEUKINPhase 1

Mecanismo: Interleukin-2 receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

734 variantes patogênicas registradas no ClinVar.

🧬 CPT2: NM_000098.3(CPT2):c.323del (p.His108fs) ()
🧬 CPT2: NM_000098.3(CPT2):c.1808_1831del (p.Ala603_Phe610del) ()
🧬 CPT2: NM_000098.3(CPT2):c.1821dup (p.Asp608Ter) ()
🧬 CPT2: NM_000098.3(CPT2):c.733G>T (p.Val245Phe) ()
🧬 CPT2: NM_000098.3(CPT2):c.1838G>A (p.Gly613Glu) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1.799 variantes classificadas pelo ClinVar.

989
810
VUS (55.0%)
Benigna (45.0%)
VARIANTES MAIS SIGNIFICATIVAS
TRAF3: NM_145725.3(TRAF3):c.233C>A (p.Ala78Glu) [Uncertain significance]
LOC126862065: NM_145725.3(TRAF3):c.651+4G>A [Uncertain significance]
TLR3: NM_003265.3(TLR3):c.2552T>G (p.Phe851Cys) [Uncertain significance]
TRAF3: NM_145725.3(TRAF3):c.1466C>T (p.Pro489Leu) [Uncertain significance]
DBR1: NM_016216.4(DBR1):c.461G>A (p.Arg154Lys) [Uncertain significance]

Vias biológicas (Reactome)

71 vias biológicas associadas aos genes desta condição.

PPARA activates gene expression Carnitine shuttle ISG15 antiviral mechanism Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Transport of the SLBP independent Mature mRNA Transport of the SLBP Dependant Mature mRNA Transport of Mature mRNA Derived from an Intronless Transcript Transport of Mature mRNA derived from an Intron-Containing Transcript Rev-mediated nuclear export of HIV RNA Transport of Ribonucleoproteins into the Host Nucleus NS1 Mediated Effects on Host Pathways Viral Messenger RNA Synthesis NEP/NS2 Interacts with the Cellular Export Machinery Regulation of Glucokinase by Glucokinase Regulatory Protein Nuclear import of Rev protein Vpr-mediated nuclear import of PICs snRNP Assembly Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion SUMOylation of DNA damage response and repair proteins SUMOylation of ubiquitinylation proteins Nuclear Pore Complex (NPC) Disassembly Regulation of HSF1-mediated heat shock response SUMOylation of SUMOylation proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) RHO GTPases Activate Formins tRNA processing in the nucleus Mitotic Prometaphase HCMV Early Events IRF3 mediated activation of type 1 IFN DDX58/IFIH1-mediated induction of interferon-alpha/beta Regulation of innate immune responses to cytosolic DNA STAT6-mediated induction of chemokines IRF3-mediated induction of type I IFN PINK1-PRKN Mediated Mitophagy TNFR1-induced proapoptotic signaling Regulation of TNFR1 signaling Interleukin-37 signaling TICAM1-dependent activation of IRF3/IRF7 TRAF3-dependent IRF activation pathway TRAF6 mediated IRF7 activation Negative regulators of DDX58/IFIH1 signaling Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) Potential therapeutics for SARS SARS-CoV-1 activates/modulates innate immune responses SARS-CoV-2 activates/modulates innate and adaptive immune responses Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation Trafficking and processing of endosomal TLR Toll Like Receptor 3 (TLR3) Cascade TICAM1, RIP1-mediated IKK complex recruitment RIP-mediated NFkB activation via ZBP1 TLR3 deficiency - HSE UNC93B1 deficiency - HSE TICAM1 deficiency - HSE TRAF3 deficiency - HSE TLR3-mediated TICAM1-dependent programmed cell death TICAM1,TRAF6-dependent induction of TAK1 complex RSV-host interactions Caspase activation via Death Receptors in the presence of ligand MyD88-independent TLR4 cascade TRIF-mediated programmed cell death IKK complex recruitment mediated by RIP1 TRAF6-mediated induction of TAK1 complex within TLR4 complex IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation TNFR2 non-canonical NF-kB pathway TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Ovarian tumor domain proteases

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado4
3Fase 36
2Fase 222
1Fase 112
·Pré-clínico65
Medicamentos catalogadosEnsaios clínicos· 9 medicamentos · 100 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Encefalite

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 26 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

48 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT07432113 · Prediction of Infectious Agents in the Biofire® FilmArray bi…Recrutando
NA🇧🇷 Brasil
NCT07852936 · Group-based Emotional Awareness and Expression Therapy to Su…Recrutando
NA🇸🇪 Suécia
NCT07707739 · Plasma Exchange in Pediatric Autoimmune EncephalitisRecrutando
NA🇪🇬 Egito
NCT07822776 · Efgartigimod in Anti-NMDA Receptor Encephalitis.Recrutando
PHASE2🇨🇳 China
NCT07093333 · A Study in Participants With Anti-NMDAR Encephalitis and Ant…Recrutando
PHASE2South Korea
NCT07526493 · Safety and Pharmacodynamics of QH103 Cell Injection in the T…Recrutando
PHASE1🇨🇳 China
NCT07488117 · Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in A…Recrutando
PHASE2🇫🇷 França
NCT07337785 · CD19/BCMA-Targeted UCAR-T for Patients With Neurological Aut…Recrutando
EARLY_PHASE1🇨🇳 China
NCT07332234 · Optic Nerve Ultrasound for Assessing Cerebral Inflammation a…Recrutando
Romania
NCT07158229 · Long-term Impact of NMDAR Encephalitis, Level 3Recrutando
🇫🇷 França
NCT06863974 · High-throughput Omic Technology for Identification of Biomar…Recrutando
NA🇫🇷 França
NCT07496749 · KD Treatment for Super-refractory Status EpilepticusRecrutando
NA🇨🇳 China
NCT07477015 · Study of Pathogenic Mechanisms and Identification of Novel A…Recrutando
🇮🇹 Itália
NCT06939166 · Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) The…Recrutando
EARLY_PHASE1🇨🇳 China
NCT06510283 · Efficacy and Safety of Taitacept in Treatment of Refractory …Recrutando
PHASE2🇨🇳 China
NCT06368648 · CoMind Early Feasibility StudyRecrutando
🇺🇸 Estados Unidos
NCT06867991 · Safety and Efficacy of Combined B Cell Depleting theRapy And…Recrutando
PHASE3🇨🇳 China
NCT06584045 · Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adul…Recrutando
NA🇨🇳 China
NCT07133113 · Medium-term Effects of Treatments in Autoimmune EncephalitisRecrutando
🇫🇷 França
NCT06502015 · Biomarkers in Autoimmune Disease of Nervous SystemRecrutando
🇨🇳 China
NCT06079294 · Impact of Confirmed Autoimmune Encephalitis on Brain Glucose…Recrutando
NA🇫🇷 França
NCT07584525 · Dexamethasone in Tick-borne EncephalitisRecrutando
PHASE3Slovenia
NCT07653984 · Cohort Study on Neuroimmune Diseases in the Reproductive AgeRecrutando
🇨🇳 China
NCT07191223 · Evaluation of Knowledge on Tick-borne Encephalitis Virus (TB…Recrutando
🇫🇷 França
NCT06515106 · Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, a…Recrutando
NA🇪🇸 Espanha
NCT07251049 · Acute Infectious Encephalitis and Myelitis in Guadeloupe by …Recrutando
Guadeloupe
NCT07614074 · Recovery Trajectory for Coma and Disorders of ConsciousnessRecrutando
🇺🇸 Estados Unidos
NCT06388161 · Neural Autoantibody Prevalence in New-onset Focal Seizures o…Recrutando
🇨🇳 China
NCT05586581 · SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV…Recrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT07274046 · Burden of Tick-borne Encephalitis and Cost-effectiveness of …Recrutando
🇨🇿 Tchéquia
NCT06019975 · FDG-PET in the Diagnosis of Autoimmune EncephalitisRecrutando
🇮🇹 Itália
NCT05566392 · Longterm Influence of Pediatric Long COVID SyndromeRecrutando
🇹🇼 Taiwan
NCT05198661 · Paraneoplastic Neurological Syndromes and Autoimmune Encepha…Recrutando
NA🇫🇷 França
NCT05393492 · Regulating Emotions and Behaviors After Brain InjuryRecrutando
NA🇫🇷 França
NCT06173076 · A Prospective Study to Evaluate Clinical Outcomes in Anti-LG…Recrutando
🇨🇳 China
NCT04372615 · The ExTINGUISH Trial of Inebilizumab in NMDAR EncephalitisRecrutando
PHASE2🇳🇱 Países Baixos · 🇪🇸 Espanha · 🇺🇸 Estados Unidos
NCT05772611 · Characterization of Immune-response in Autoimmune Encephalit…Recrutando
🇫🇷 França
NCT06852703 · Predictive BioMArkers of AlTERed NeurologicAL Trajectories C…Recrutando
🇮🇹 Itália
NCT04561557 · Safety and Efficacy of CT103A Cells for Relapsed/Refractory …Recrutando
EARLY_PHASE1🇨🇳 China
NCT03993262 · Trial to Evaluate Efficacy and Safety of Bortezomib in Patie…Recrutando
PHASE2🇩🇪 Alemanha
NCT05017142 · Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-P…Recrutando
🇨🇭 Suíça
NCT02979951 · Fosfomycin I.v. for Treatment of Severely Infected PatientsRecrutando
🇦🇹 Áustria · 🇩🇪 Alemanha · Greece +2
NCT02890641 · Genetic and Electrophysiologic Study in Focal Drug-resistant…Recrutando
🇫🇷 França
NCT02479698 · Cytotoxic T Lymphocytes in Treating Patients With Malignanci…Recrutando
PHASE2🇺🇸 Estados Unidos
NCT03418441 · Central Nervous System Infections in DenmarkRecrutando
🇩🇰 Dinamarca
NCT03956446 · Tick-borne Encephalitis and Borrelial Antibodies in SerumRecrutando
NASlovenia
NCT01730131 · Natural History Study of Progressive Multifocal Leukoencepha…Recrutando
🇺🇸 Estados Unidos
NCT07186881 · Evolving Diagnostic Approaches to Undocumented Lymphocytic M…Por convite
🇫🇷 França

Outros ensaios clínicos

340 ensaios clínicos encontrados, 81 ativos.

Distribuição por fase
NCT07583641 · A Study to Learn About How Well the Medicine Efgartigimod Wo…Em breve
PHASE2🇺🇸 Estados Unidos
NCT07783269 · A Basket Study of CTA313 in Participants With Active Autoimm…Em breve
PHASE1
NCT07856043 · [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure …Em breve
PHASE1🇺🇸 Estados Unidos
NCT07858175 · Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based …Em breve
🇨🇳 China
NCT07830927 · Early Neurological Outcome in Pediatric EncephalitisEm breve
NCT07804004 · A Safety and Efficacy Study Evaluating CTX112 in Subjects Wi…Em breve
PHASE1, PHASE2
NCT07686042 · Efficacy and Safety of Low-Dose Blinatumomab in the Treatmen…Em breve
PHASE4🇨🇳 China
NCT07333196 · Tongji NADs CohortEm breve
🇨🇳 China
NCT07341828 · A Study of C-CAR168 in the Treatment of Central Nervous Syst…Em breve
PHASE1
NCT07241858 · Clinicolaboratory Predictors of Outcome in Children With Enc…Em breve
🇪🇬 Egito
NCT07377253 · First-in-Human Study Testing a New Antibody Treatment for Ti…Em breve
PHASE1🇨🇭 Suíça
NCT07131683 · hUC-MSC-Exo Therapy for Autoimmune EncephalitisEm breve
PHASE1, PHASE2
NCT06674837 · Diagnostics and Surveillance of Acute Meningo-encephalitis A…Em breve
NCT07088822 · A Phase 1 Study Evaluating the Safety, Tolerability, and Imm…Em breve
PHASE1🇺🇸 Estados Unidos
NCT06177028 · MCLENA-2: A Phase II Clinical Trial for the Assessment of Le…Em breve
PHASE2
NCT06971133 · Causes of Secondary and Prolonged Fever During Treatment of …Em breve
NCT06859619 · Serological Measurement of Montpellier Professionals' Contac…Em breve
NA🇫🇷 França
NCT06849011 · Inflammatory and Metabolic Prognostic Assessment in Critical…Em breve
🇨🇳 China
NCT06760091 · A Multicentric Cohort of Autoimmune EncephalitisEm breve
🇨🇳 China
NCT06697678 · Risk Prediction Model for Severe Autoimmune EncephalitisEm breve
NCT05503264 · A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (…Ativo
PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇨🇳 China +12
NCT07689682 · OPM- MEG in Non-immune And iMmune-medIated Neurological Dise…Ativo
NA🇬🇧 Reino Unido
NCT06978582 · Effectiveness and Safety of a Tele-Rehabilitation Program on…Ativo
NA🇪🇸 Espanha
NCT07200687 · Effects of Combined Music Therapy and Occupational Therapy o…Ativo
NAGreece
NCT06820060 · Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis …Ativo
🇬🇧 Reino Unido
NCT06899802 · A Phase 2 Trial in Healthy Adult Participants of the Recombi…Ativo
PHASE2🇺🇸 Estados Unidos
NCT06678373 · Monitoring JE Antibody Levels in Healthy Populations and Imm…Ativo
PHASE4🇨🇳 China
NCT06825312 · Immunogenicity, Safety, and Antibody Persistence of Differen…Ativo
PHASE4🇨🇳 China
NCT07145502 · Monitoring of Outcomes of Cellular and Exosome-based Therapi…Ativo
🇵🇱 Polônia
NCT05728931 · New Biomarkers in Auto-immune Encephalitis and Neurological …Ativo
🇫🇷 França
NCT05138055 · The NOrwegian Tick-borne Encephalitis StudyAtivo
🇳🇴 Noruega
NCT03194815 · IVIG and Rituximab in Antibody-associated Psychosis - SINAPP…Ativo
PHASE2🇬🇧 Reino Unido
NCT00716066 · Autologous Stem Cell Transplant for Neurologic Autoimmune Di…Ativo
PHASE2🇺🇸 Estados Unidos
NCT04190303 · BIGlobal Intervention Study: Improving Diagnosis and Managem…Concluído
🇧🇷 Brasil · 🇮🇳 Índia · Malawi
NCT05370573 · Brazil ICU Encephalitis SurveillanceConcluído
🇧🇷 Brasil
NCT07554261 · Clinical Features and Outcomes of VZV CNS InfectionsConcluído
Turkey (Türkiye)
NCT06753955 · Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy…Concluído
PHASE1🇦🇺 Austrália
NCT06680128 · A Study to Assess the Safety, Reactogenicity, and Immunogeni…Concluído
PHASE1, PHASE2🇦🇺 Austrália · New Zealand
NCT06609044 · Long-term Impact of NMDAR EncephalitisConcluído
🇫🇷 França
NCT06575153 · Phase 1 Study of ART5803 in Healthy ParticipantsConcluído
PHASE1🇦🇺 Austrália
NCT06915103 · A Case Report of NMDAR EncephalopathyConcluído
🇺🇸 Estados Unidos
NCT06720519 · Molecular Panel Evaluation for Diagnosis of Infections of th…Concluído
🇮🇹 Itália
NCT06331702 · Immunogenicity of Japanese Encephalitis Vaccine Co-administe…Concluído
PHASE4🇨🇳 China
NCT06372665 · Safety Observation of the Japanese Encephalitis Vaccine Give…Concluído
🇨🇳 China
NCT05954468 · Psycho-social Impact of Anti-NMDAR EncephalitisConcluído
🇫🇷 França
NCT06033846 · Efficacy and Safety of Adjunctive Minocycline in the Treatme…Concluído
PHASE2🇨🇳 China
NCT05941546 · Tick-borne Encephalitis Virus Research in LimousinConcluído
🇫🇷 França
NCT06067750 · Comparison of Narcotrend and Cerebral Function Analysing Mon…Concluído
🇬🇧 Reino Unido
NCT05777499 · MUSic Therapy In Complex Specialist NeurorehabilitationConcluído
NA🇬🇧 Reino Unido
NCT06593249 · Management of Tick-borne EncephalitisConcluído
Slovenia
NCT05413733 · Neuropsychological Rehabilitation Over the InternetConcluído
NA🇫🇮 Finlândia
NCT05825690 · BRIEF TITLE * (in English and Sufficiently Descriptive) Role…Concluído
🇫🇷 França
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
23.325 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 23.325

#1

Fixel-Based Analysis of Pretreatment MRI Identifies White Matter Abnormalities in Pediatric Anti-NMDAR Encephalitis.

Journal of child neurology2026 Mar 25

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder in which conventional MRI often appears normal, leading to clinical-radiologic dissociation and hindering early diagnosis and monitoring. We retrospectively studied five pediatric patients with anti-NMDAR encephalitis and compared their pretreatment diffusion MRI to age- and sex-matched controls. Using fixel-based analysis (FBA), we quantified tract-specific white matter abnormalities at the individual level. All patients showed significantly reduced fiber density and cross-section, with patterns ranging from focal to widespread involvement. In two patients, FBA abnormalities corresponded to seizure lateralization on EEG despite normal MRI, emphasizing FBA's added value in detecting seizure-concordant injury. One patient, exhibiting the highest disease burden and marked CSF pleocytosis, demonstrated extensive white matter tract disruption. These findings indicate that FBA derived from pretreatment MRI can identify clinically significant white matter injury at disease onset in pediatric anti-NMDAR encephalitis. Future large-scale studies should explore its potential as an individualized biomarker, which may offer diagnostic and prognostic value beyond conventional imaging.

#2

[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.

Annals of clinical and translational neurology2026 Mar 24

To evaluate [18F]fluorodeprenyl-D2 ([18F]F-DED) positron-emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. [18F]F-DED PET was performed in 25 GAD65-AIE patients and 8 controls using dynamic (0-60 min) and static (30-60 min) acquisitions. Global astrogliosis was assessed by volumes of distribution (VT; 1-tissue-compartment model with carotid input) and standardized uptake values (SUV). Regional cerebellar and mesiotemporal (MT) uptake was normalized to global uptake (SUVr). PET measures were correlated with clinical phenotypes, MRI findings, and serum biomarkers (neurofilament light chain [sNfL], GAD65-Ab titers, and glial fibrillary acidic protein [sGFAP]). Clinical phenotypes included limbic encephalitis/temporal lobe epilepsy (LE/TLE; n = 17), stiff-person syndrome (n = 4), and cerebellar ataxia (CA; n = 4), with overlap in nine patients. Global [18F]F-DED uptake was higher in patients than controls. VT analysis showed increased cortical and MT uptake, while SUVr analysis demonstrated elevated MT uptake across the cohort. LE/TLE patients exhibited increased MT uptake, and CA patients showed higher cerebellar uptake. [18F]F-DED uptake did not correlate with sNfL or GAD65-Ab titers, but sGFAP showed associations with cerebellar and white-matter uptake. Regional uptake correlated with clinical severity in LE/TLE (MT lobe) and CA (cerebellar white matter). [18F]F-DED PET reveals region-specific astrogliosis corresponding to clinical manifestations and disease severity in GAD65-AIE, supporting its potential as a monitoring tool for disease activity.

#3

Population-Based Epidemiology of Autoimmune Seizures and Epilepsies.

Annals of neurology2026 Mar 24

To estimate the prevalence, incidence, and disease burden of autoimmune seizures and epilepsies in Olmsted County. We conducted a retrospective, population-based study using the Rochester Epidemiology Project (1996-2019). Age- and sex-standardized rates (2019 United States standard population) per 100,000 were calculated with 95% confidence intervals (95% CIs). Temporal trends in incidence were assessed over 3 consecutive 8-year intervals (1996-2003, 2004-2011, and 2012-2019) using Poisson regression to estimate rate ratios per period and trend. Disability-adjusted life years (DALYs), years of life lost (YLL), and years lived with disability (YLD) and 95% uncertainty intervals (95% UIs) were estimated for 2019. Twenty-three patients were identified between 1996 and 2019. In 2019, the standardized prevalence of all autoimmune seizures and epilepsies was 9.81 (95% CI, 5.59-15.21) per 100,000, including autoimmune-associated epilepsy (AAE) 7.27 (3.74-11.95) and acute symptomatic seizures secondary to autoimmune encephalitis (ASSAE) 2.55 (0.69-5.60). From 1996 to 2019, the standardized incidence was 0.50 (0.29-0.77) per 100,000 person-years overall, with AAE 0.36 (0.19-0.59) and ASSAE 0.15 (0.05-0.30). By period, the standardized incidence of all autoimmune seizures and epilepsies suggested a rising trend from 0.28 (95% CI, 0.06-0.68) in 1996 to 2003 to 0.60 (95% CI, 0.24-1.12) in 2004-2011, then plateaued at 0.53 (95% CI, 0.21-1.00) in 2012 to 2019 (rate ratio per 8-year interval 1.30, 95% CI, 0.71-2.38), largely driven by the seropositive subgroup. The standardized DALY rate was 26.27 (95% Uncertainly intervals [UI], 5.30-67.09) per 100,000 (YLL 20.07 [0.00-60.21] and YLD 6.20 [5.06-7.39]). Although autoimmune seizures and epilepsies remain rare, they result in a disproportionately high disease burden. ANN NEUROL 2026.

#4

Inactivated Japanese encephalitis virus vaccination imprints fusion loop-biased antibody responses that are attenuated by repeated live-attenuated dengue vaccination.

medRxiv : the preprint server for health sciences2026 Mar 02

Immune imprinting, also known as immune history, is a core aspect of adaptive immunity that influences antibody responses to future antigen exposures. Nevertheless, the impact of sequential flavivirus vaccinations on epitope targeting and antibody activity in humans remains incompletely understood. This question is particularly important in regions where the inactivated Japanese encephalitis virus (JEV) vaccines and the live-attenuated dengue virus (DENV) vaccines are used, as both have been associated with an increased risk of symptomatic dengue infection and severe illness. We studied the impact of prior inactivated JEV IXIARO vaccination and simultaneous vaccination on humoral immunity following live-attenuated dengue CYD-TDV vaccination. Long-term analysis showed that JEV IXIARO priming guides the dengue vaccine-induced antibody response toward conserved fusion loop epitopes (FLEs) of the DENV envelope protein, as indicated by 4G2 FLE-bias. This imprinting was characterized by higher levels of 4G2 FLE-like antibodies, rapid recall responses after dengue vaccination, and broad but low-potency neutralization across dengue serotypes and Zika virus. Notably, 4G2 FLE-focused responses correlated with higher FcγRIIa-mediated antibody-dependent enhancement relative to neutralization potency, suggesting functional effects beyond neutralization. To better understand epitope dominance within the native envelope, we used a structurally defined fusion loop epitope mutant (FLE-mut) envelope dimer assay. Disrupting fusion loop accessibility significantly decreased antibody binding, confirming that FLE-specific antibodies are a major component of the response after sequential vaccination. Importantly, a complete series of live-attenuated dengue vaccine reduced 4G2 FLE bias, encouraged the recruitment of non-fusion-loop epitopes, and lessened FcγRIIa-biased antibody activity. Overall, these results show that vaccination platform, timing, and regimen are critical determinants of epitope dominance and antibody quality following flavivirus vaccination.

#5

Clinico-etiological profile and prognostic factors of acute febrile encephalopathy in children: a prospective study from Indian subcontinent.

Journal of tropical pediatrics2026 Feb 09

Acute febrile encephalopathy (AFE) is a common neurological emergency in all age groups. In tropical regions, long-standing infections such as Japanese encephalitis and bacterial meningitis continue to be major causes of AFE, while changing presentations of familiar infections and newly emerged diseases like COVID-19 are also becoming increasingly notable. To describe various clinical presentations, etiology and mortality of AFE in pediatric age group. This prospective observational study was undertaken in a tertiary care institute of Northern India from April 2022 to April 2023. Children aged 1 month to 18 years presenting to the pediatric emergency department with fever of <2 weeks duration and altered sensorium lasting >24 hours were eligible for inclusion. A total of 100 patients (49% males) with AFE were enrolled. The mean (SD) duration of encephalopathy was 1.39 (0.69) days. The most frequent etiologies were viral encephalitis (17%), dengue encephalopathy (12%), and hepatic encephalopathy (9%). The peak incidence occurred between August and November. The overall case fatality rate was 33%. Under-5 children with severe acute malnutrition (SAM) had the highest fatality rate (56%, 9/16). Among survivors, 16% (11/67) had poor functional outcomes. Higher odds of mortality were observed in patients with a Glasgow coma scale score <8, hypoglycemia at admission, requirement for mechanical ventilation or inotropic support, and presence of multiorgan dysfunction. AFE demonstrates a predictable seasonal pattern and is associated with high mortality and morbidity, particularly in under-5 children with SAM, who represent the most vulnerable group.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC31.530 artigos no totalmostrando 199

2026

Fixel-Based Analysis of Pretreatment MRI Identifies White Matter Abnormalities in Pediatric Anti-NMDAR Encephalitis.

Journal of child neurology
2026

Case Report: Immune checkpoint inhibitor-triggered anti-Ma2 paraneoplastic encephalitis in sarcomatoid pleural mesothelioma: a fatal case.

Frontiers in oncology
2026

Analysis of the Clinical Features of HSV-2 Encephalitis Confirmed by the mNGS Technique: Insights Derived from Seven Patient Studies.

Infection and drug resistance
2026

Knockdown resistance (kdr) mutations in the Japanese encephalitis virus vector Culex tritaeniorhynchus from the Republic of Korea.

Tropical medicine and health
2026

[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Population-Based Epidemiology of Autoimmune Seizures and Epilepsies.

Annals of neurology
2026

[A cohort study on the association between lactate to albumin ratio and 28-day in-hospital all-cause mortality in critically ill children].

Zhonghua wei zhong bing ji jiu yi xue
2026

Confusion beyond the usual suspects.

Journal of infection and public health
2026

Clinical characteristics and surgical outcomes of Rasmussen encephalitis: A retrospective dual-center cohort study.

Epilepsia
2026

Infection and Vaccination-Induced Tick-Borne Encephalitis Virus IgG Antibody Prevalence in the Austrian Federal State of Upper Austria, a High-Risk Region for TBEV.

Epidemiologia (Basel, Switzerland)
2026

Concurrent Detection of Streptococcus pneumoniae and Herpes Simplex Virus Type 1 (HSV-1) in Cerebrospinal Fluid: Clinical Interpretation Beyond Molecular Positivity.

Cureus
2026

Sporadic Creutzfeldt-Jakob Disease With Spinal Cord Lesions: A Case Report.

Cureus
2026

Acute Necrotizing Encephalopathy of Childhood: A Report of Two Cases.

Cureus
2026

Projecting tick-borne encephalitis risk in Sweden under climate change scenarios: a high-resolution spatio-temporal modeling approach.

Environmental health : a global access science source
2026

Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series.

Frontiers in immunology
2026

Influenza A-Associated Acute Necrotizing Encephalitis With Complete Recovery Following Early Immunomodulatory Therapy.

Cureus
2026

Varicella-Zoster Virus Infection in an Immunocompromised Patient With Seizure-Like Activity and Septic Shock: A Case Report.

Cureus
2026

Umbelliferone Inhibits Zika Virus (ZIKV) NS5 Activity and Replication In Vitro.

ACS omega
2026

Cases of Septic Arthritis During Meningitis Infection at Zinder National Hospital, Niger Republic.

International medical case reports journal
2026

Inactivated Japanese encephalitis virus vaccination imprints fusion loop-biased antibody responses that are attenuated by repeated live-attenuated dengue vaccination.

medRxiv : the preprint server for health sciences
2026

Glymphatic system dysfunction in epilepsy: a review of mechanisms and clinical evidence.

Encephalitis (Seoul, Korea)
2026

Development and evaluation of an assay for the detection of tick-borne encephalitis virus RNA via real-time PCR with reverse transcription.

Parasites &amp; vectors
2026

Clinico-etiological profile and prognostic factors of acute febrile encephalopathy in children: a prospective study from Indian subcontinent.

Journal of tropical pediatrics
2026

Experimental modeling of Acanthamoeba keratitis in mice: Isolation and cultivation of Acanthamoeba castellanii.

Experimental eye research
2026

Recommendations for a Pediatric Catatonia Clinical Pathway in Acute Medical Care Settings: A Delphi Consensus Study.

Journal of the Academy of Consultation-Liaison Psychiatry
2026

Single-institution experience with efgartigimod in patients with GFAP astrocytopathy: Treatment response and adverse events.

Multiple sclerosis and related disorders
2026

Towards national guidance on dengue and chikungunya vaccination in travellers: Lessons from global recommendations.

Travel medicine and infectious disease
2026

Severe Varicella-Zoster Virus Encephalitis with Extreme Cerebrospinal Fluid Protein Elevation and Delayed Hydrocephalus in an Immunocompetent Patient in Shanghai.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

The Lancet. Neurology
2026

Therapeutic perspectives in refractory anti-NMDA receptor encephalitis.

The Lancet. Neurology
2026

Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ).

Vaccine
2026

Global burden shift from infectious to non-communicable neurological disorders in adolescents and young adults (10-24 years): findings from the global burden of disease study 1990-2021.

International journal of clinical pharmacy
2026

Pituitary abscess, plexus-choroiditis and encephalitis by Helcococcus ovis in a calf.

Veterinary research communications
2026

Progress and Innovation in Japanese Encephalitis Vaccines: Toward Global Immunization.

Recent advances in anti-infective drug discovery
2026

Endoplasmic reticulum stress inhibitor 4-PBA alleviates immune damage in mice with enteroviral encephalitis by inhibiting ferroptosis.

Virology journal
2026

Clinical characteristics of autoimmune GFAP astrocytopathy with concomitant Epstein-Barr virus positivity: a case series of 12 patients and literature review.

Journal of neurology
2026

Venezuelan equine encephalitis virus: novel live-attenuated vaccines for inducing complete protective immunity.

Npj viruses
2026

An Atypical Presentation of Autoimmune Encephalitis.

The primary care companion for CNS disorders
2026

A time-varying geospatial model of habitat suitability for Japanese encephalitis virus vectors and vertebrate hosts in Australia.

PLoS neglected tropical diseases
2026

Anti-NMDA receptor encephalitis in the setting of inherited chromosomally integrated human herpesvirus 6B (iciHHV-6B): A case report.

IDCases
2026

Combination Versus Monotherapy in Acute Anti-LGI1 Encephalitis: A Real-World Dose Optimization Analysis.

Neuropsychopharmacology reports
2026

Regenerative Nodule as a Diagnostic Dilemma in the Neonate With Acute Liver Failure and a Focal Liver Lesion.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2026

Myelin-oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis initially considered viral meningitis.

QJM : monthly journal of the Association of Physicians
2026

Central nervous system pericytes express soluble ST2 in inflammation and injury.

Molecular brain
2026

Isolation and characterization of Japanese encephalitis virus genotype I from pig provides evidence for the presence of the virus in nasal secretion and co-circulation of JEV genotypes in Assam, India.

Frontiers in cellular and infection microbiology
2026

Clinical profile and treatment outcomes of patients with chronic presentations of autoimmune encephalitis: expanding the spectrum.

BMJ neurology open
2026

Cat Scratch Disease as an Under-recognised Cause of Subacute Meningitis.

Emerging microbes &amp; infections
2026

Enterovirus 71: The Emerging Threat of Encephalitis in Nepal.

Journal of Nepal Health Research Council
2026

Acute cerebral blood flow and its connectivity in patients with anti-LGI1 autoimmune encephalitis: an arterial spin labeling study.

Brain imaging and behavior
2026

Vital Prognosis and Causes of Death in Adults with Encephalitis.

Neurocritical care
2026

Clinical characteristics, laboratory findings, and risk factors for severe tick-borne encephalitis (TBE) in northeastern Poland: analysis of 1654 hospitalized cases between 1993 and 2023.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Cerebral glucose metabolism basis of prognostic differences between paraneoplastic and non-paraneoplastic anti-GABABR encephalitis.

Neuroscience letters
2026

Complications and long-term sequelae of tick-borne encephalitis: association with age and other predictors - a multicenter observational study.

Ticks and tick-borne diseases
2026

Investigation of neurotropic arboviruses in wild and domestic animals in Amazon region, 2023-2024.

Memorias do Instituto Oswaldo Cruz
2026

Clinical Profiles and Outcomes of Adult Patients With Central Nervous System Infections: A Descriptive Cross-Sectional Study at a Single Private Tertiary Hospital in Quezon City, Philippines.

Cureus
2026

High burden of autochthonous arboviral infections during the summer season in Verona province, Italy, during 2025.

The Journal of infection
2026

Pathogens of the Human Central Nervous System- the Major Bacterial Pathogens.

Molecular neurobiology
2026

Spatial transcriptomics uncovers vasculature-centered cellular interactions driving Japanese encephalitis progression in a mouse model.

Nature communications
2026

Chikungunya viral load in cerebrospinal fluid and blood is not associated with severity of neurological manifestations in children.

PLoS neglected tropical diseases
2026

Signal peptide variation in cyst lectins as a potential marker for pathogenic Acanthamoeba spp.

Parasites &amp; vectors
2026

Epidemiology of tick-borne diseases diagnosed in patients in north-eastern Italy, 2015-2022.

BMC infectious diseases
2026

Neurological immune-related adverse events of immune-checkpoint inhibitors: an updated review.

Presse medicale (Paris, France : 1983)
2026

Genistein mitigates estrogen deficiency and chronic stress-induced neuronal dysfunction via targeting ER-β, oxidative stress, inflammation, and apoptosis.

Neuromolecular medicine
2026

Refractory anti-NMDA receptor encephalitis driven by a contralateral ovarian teratoma following unilateral oophorectomy: a case report.

International journal of surgery case reports
2026

Causal neurodevelopmental origins of scoliosis: Multi-omics Mendelian randomization reveals brain-region-specific pathways and protein mediators.

Journal of orthopaedic translation
2026

Immune checkpoint inhibitor-related encephalitis overlapping with hyperprogression in metastatic lung cancer: a case report.

Frontiers in immunology
2026

Hemophagocytic lymphohistiocytosis directly triggered by peginterferon alfa-2b in a patient with chronic hepatitis B.

Frontiers in immunology
2026

Testing for neural antibodies in autoimmune encephalitis: who, what, where, when, why, and how.

Therapeutic advances in neurological disorders
2026

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts.

Journal of human immunity
2026

In coronavirus patients with impaired consciousness, comprehensive and repeated examinations are necessary to determine the cause.

Encephalitis (Seoul, Korea)
2026

Identification of nonconvulsive status epilepticus in the ictal-interictal continuum using artificial intelligence: a prospective observational cohort study.

Encephalitis (Seoul, Korea)
2026

A Case of Cerebral Cortical Encephalitis.

Annals of clinical and translational neurology
2026

Antibodies against tick-borne pathogens in domestic dogs in Norway: Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and Anaplasma phagocytophilum.

Acta veterinaria Scandinavica
2026

Pediatric anti-NMDAR encephalitis: Neuroradiological presentation, cognitive outcome and volumetric MRI analysis.

NeuroImage. Clinical
2026

Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium.

Multiple sclerosis and related disorders
2025

Tuberculosis Meningo-encephalitis in Casablanca, Morocco.

La Tunisie medicale
2026

Antiviral effect of chelerythrine chloride against tick-borne encephalitis virus.

Virology journal
2026

Tuberculous meningitis presenting as MERS Type II syndrome: A case report.

The Indian journal of tuberculosis
2026

Pathogenic mechanisms of action of autoantibody-mediated central nervous system disorders targeting neuroglial surface antigens.

Autoimmunity reviews
2026

Distinct cerebrospinal fluid profiles of astrocytic aquaporin-4 and GFAP in neuroinflammatory disorders.

Neurobiology of disease
2026

Anti-NMDAR antibody exposure induces cognitive inflexibility and prefrontal GABAergic dysregulation in mice.

Experimental neurology
2026

GAD65 encephalitis presenting with isolated refractory vomiting: a pivotal mimic of functional disorder.

Acta neurologica Belgica
2026

Mycoplasma pneumoniae-associated meningo-encephalitis: A case report.

Tropical doctor
2026

Systematic Review of Alkaloids and Their Analogues as Therapeutic Agents for Human Herpesvirus Infection.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Faster Results, Better Care? Impact of Meningitis/Encephalitis Syndromic Panel Testing on Pathogen Detection and Hospital Outcomes Beyond CSF Culture: A Literature Search for Diagnosticians.

Diagnostics (Basel, Switzerland)
2026

The Role of Viral Load in COVID-19-Induced Encephalitis.

Journal of clinical medicine
2026

Biochemical, molecular, and in silico insights into the effects of cyphenothrin on Culex quinquefasciatus mosquitoes.

Parasites &amp; vectors
2026

Herpes simplex virus type 2 encephalitis in critically ill adults: A retrospective analysis of EURECA and Herpetics cohort studies.

Critical care (London, England)
2026

Synaptic dysfunction and adaptation after NMDA receptor ablation in the mouse medial prefrontal cortex.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2026

Efficient use of the BioFire® FilmArray® Meningitis/Encephalitis Panel: a diagnostic stewardship approach.

Internal medicine journal
2026

DETECTION OF WEST NILE VIRUS AND ST. LOUIS ENCEPHALITIS VIRUS IN THE TEXAS PANHANDLE AND HIGH PLAINS REGION, USA, IN 2024.

Journal of the American Mosquito Control Association
2026

Non-polio enterovirus infection and electrophysiological changes in human iPSC-derived neural networks.

EBioMedicine
2026

Enucleated cells with Nectin-1 overexpression capture HSV-1 and promote viral elimination for herpes simplex encephalitis therapy.

Cell reports
2026

Neuroanatomical localization of faciobrachial dystonic seizures in LGI1-antibody encephalitis.

Epilepsia
2026

Modelling Aedes albopictus management, incorporating immigration and bi-directional Wolbachia interactions.

Journal of pest science
2026

CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy.

Journal of neuroinflammation
2026

Incidence of Childhood Stroke and Association With Recent Infection: A Population-Based Study Using Linked Data.

Neurology
2026

Neonatal Listeria Meningitis Showing the Limits of the FilmArray Meningitis/Encephalitis Panel® and the Potential Use of Serum.

Indian journal of pediatrics
2026

Radiological Features of Encephalitis of Chlamydia psittaci.

Neurology India
2026

Visual Disturbance and Elevated Glutamic Acid Decarboxylase Antibody Levels as Manifestations of Central Nervous System Lymphoma.

Neurology India
2026

Evaluation of the vector competence of Ixodes persulcatus in the maintenance and transmission of Alongshan virus under laboratory conditions.

Frontiers in cellular and infection microbiology
2026

Improvement of Mycoplasma pneumoniae-Associated Acute Cerebellar Ataxia and Possible Encephalopathy After Intravenous Immunoglobulin.

Case reports in infectious diseases
2026

Proteomic Analysis of Serum and Cerebrospinal Fluid in Children with Encephalopathy Associated with Human Betaherpesvirus 6B.

Open forum infectious diseases
2026

Before status epilepticus in epilepsy patients is attributed to the SARS-CoV-2 vaccination, alternative causes must be ruled out: Status epilepticus after COVID-19 vaccination.

Seizure
2026

Alternative diagnoses of suspected paraneoplastic neurological syndromes: a population-based study.

Journal of neurology
2026

Case Report: PET/CT assessment of immunomodulatory therapy in anti-IgLON5 encephalitis with sleep apnea.

Frontiers in neuroscience
2026

Machine learning-based prognostic analysis of patients with status epilepticus in the neurological intensive care unit.

Journal of critical care
2026

Adult Japanese encephalitis in a non-endemic area: A case highlighting diagnostic limitations of targeted next-generation sequencing.

Diagnostic microbiology and infectious disease
2026

Japanese encephalitis virus envelope protein activates the TLR4/NF‑κB pathway to induce testicular inflammation.

Veterinary microbiology
2026

The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management.

Advances in therapy
2026

Engineering of cell line assembled enteric organoid for enterovirus infection.

Archives of virology
2026

Post-infectious Basal Ganglia Encephalitis Caused by Mumps: A Case Series.

Journal of child neurology
2026

Observations of the developmental stages of Coquillettidia perturbans (Diptera: Culicidae) with special reference to the pupal trumpets.

Journal of insect science (Online)
2026

A Case of Fulminant West Nile Virus Encephalitis Presenting With Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) and Diagnostic Discordance.

Cureus
2026

Langat Virus Biology and Infection.

Reviews in medical virology
2026

Caffeine for the Treatment of Aseptic Immune Checkpoint Inhibitor-Induced Encephalitis.

The primary care companion for CNS disorders
2026

Morvan Syndrome Masquerading as Anxiety Disorder: A Case Report Highlighting the Importance of Recognizing Organic Signs in Psychiatric Settings.

International medical case reports journal
2026

Real-World Evaluation of the BioFire FilmArray ME Panel: Diagnostic Accuracy and Clinical Utility.

The Canadian journal of infectious diseases &amp; medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
2026

Biosensors for the detection of arthropod-borne veterinary viruses: A comprehensive review.

Veterinary and animal science
2026

Intrathecal immunoglobulin production in the diagnosis, prognosis, and monitoring of autoimmune diseases of the central nervous system.

Journal of translational autoimmunity
2026

Neuropsychiatric Presentation of Non-paraneoplastic Voltage-Gated Calcium Channel Autoimmune Encephalitis: A Case Report.

Cureus
2026

Herpes Simplex Virus Encephalitis With Cerebellar Infarction and Cortical Laminar Necrosis.

Cureus
2026

Overview of Immunotherapy Administration for Miller Fisher Syndrome in Japan: A Nationwide Retrospective Cohort Study.

Annals of clinical epidemiology
2026

Clinical features, prognosis, and influencing factors of relapse in autoimmune encephalitis associated with antibodies against cell surface antigens: a single-center retrospective study.

European journal of medical research
2026

A human cerebral organoid model of West Nile virus encephalitis shows innate immunocompetency.

Nature communications
2026

Varicella zoster virus-related myelitis: a case series and literature review.

Virology journal
2026

Clinico-virological investigation of measles complications in immunocompromised pediatric patients.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2026

Morvan syndrome associated with prominent Tau pathology: A clinicopathological case report.

Journal of neuroimmunology
2026

Non-invasive Assessment of Glymphatic System Function in Patients with Anti-LGI1 Encephalitis.

Multiple sclerosis and related disorders
2026

Molecular evidence of Japanese encephalitis virus in poultry: Need to further elucidate JEV epidemiology.

Comparative immunology, microbiology and infectious diseases
2026

Anti-GAD65 Encephalitis: A Cryptic Case Requiring a Multidisciplinary Approach.

Harvard review of psychiatry
2026

LRP8-dependent neurotropism of tick-borne encephalitis virus: From species-specific entry gateway to zoonotic spillover and receptor-mimetic therapy.

Innovation (Cambridge (Mass.))
2026

Interplay between flaviviruses and the interferon response: mechanisms of immune evasion and therapeutic implications.

Frontiers in pharmacology
2026

Neurological Infections in HIV: A Case-Based Review for Clinicians.

Le infezioni in medicina
2026

Clinical characteristics of community acquired pneumonia due to Mycoplasma pneumoniae: experience from an outbreak.

Le infezioni in medicina
2026

Antibody-Negative Nivolumab-Induced Autoimmune Encephalitis: A Case Report and Review of Seronegative Presentations.

Cureus
2026

In silico Exploration of Aegle Marmelos-Derived Compounds as Potential Inhibitors of NS5 RdRp in Japanese Encephalitis Virus.

Combinatorial chemistry &amp; high throughput screening
2026

Preliminary evidence of cardiac dysfunction in subacute sclerosing panencephalitis: a systematic review and meta-analysis.

Encephalitis (Seoul, Korea)
2026

Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results.

BMC infectious diseases
2026

Severe sleep-related hypoventilation in antibody-positive and antibody-negative autoimmune encephalitis: an emergency.

The European respiratory journal
2026

West Nile virus encephalitis in a kidney transplant recipient: a case report and review of the literature.

Clinical transplantation and research
2026

Minimally Clinically Important Difference of the Clinical Assessment Scale in Autoimmune Encephalitis.

Annals of clinical and translational neurology
2026

Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT.

EClinicalMedicine
2026

Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report.

Frontiers in immunology
2026

Modulation of innate immune responses by virus-host interactions in Orthoflavivirus.

Virology
2026

Evaluation of the Ultima Genomics UG 100 sequencer for low-cost, high-sensitivity metagenomic pathogen detection from cerebrospinal fluid.

Microbiology spectrum
2026

Tick-borne encephalitis in the Åland Islands, Finland: incidence and disease course since the implementation of a general TBE vaccination programme.

Emerging microbes &amp; infections
2026

Listeria rhombencephalitis in an alcoholic man; A case report and review of literature.

eNeurologicalSci
2026

Nivolumab-induced Limbic Encephalitis in Gastric Cancer: A Case Report and Literature Review.

Cancer diagnosis &amp; prognosis
2026

Retrospective analysis of the clinical features of 12 cases of MOG antibody-associated aseptic meningitis.

Frontiers in medicine
2026

Development and validation of a DNA-launched, intron-stabilized Langat virus infectious clone and reporter viruses.

Virology
2026

[Cognitive and psychiatric evolution in autoimmune encephalitis in a school-aged child: Clinical case].

Revista medica del Instituto Mexicano del Seguro Social
2026

Investigation of tick-borne encephalitis virus in raw ruminant milk in Turkiye using real-time PCR.

Archives of virology
2026

Deciphering Involuntary Movements: A Case of Seronegative Autoimmune Encephalitis With a Kaleidoscopic Presentation.

Cureus
2026

Brainstem encephalitis and anti-GQ1b antibody syndrome triggered by varicella-zoster virus presenting as intractable hiccups: a first reported case.

BMC neurology
2026

Neuropathogenesis of Usutu virus-associated disease in Eurasian blackbirds (Turdus merula) involves apoptosis through the extrinsic pathway.

Journal of neurovirology
2026

Chronic granulomatosis with persistent HSV intrathecal synthesis over three years: a rare complication of HSV encephalitis in adult.

Journal of neurovirology
2026

Single-cell transcriptomics reveal heat shock protein dysregulation in severe SARS-CoV-2-associated pediatric encephalopathy.

Scientific reports
2026

Sjögren Syndrome Associated Limbic Encephalitis and Its Longitudinal Brain FDG PET Manifestations.

Clinical nuclear medicine
2026

Optimization of lytic herpes simplex virus infection in human induced pluripotent stem cell-derived cortical neurones.

The Journal of general virology
2026

Chandipura Virus: A Neglected Sandfly-Borne Neurotropic Virus in Children - Insights From Seven Decades of Evidence.

Reviews in medical virology
2026

Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis.

Cureus
2026

HHV-6 Encephalitis in an Immunocompetent Child: A Steroid-Responsive Case Complicated by Cerebral Venous Sinus Thrombosis.

Sage open pediatrics
2026

Functional Hemispherectomy for Rasmussen Encephalitis in a Patient with Systemic Lupus Erythematosus and Type 1 Diabetes Mellitus: A Case Report.

International medical case reports journal
2026

Global, regional, and national burden of encephalitis from 1990 to 2021: result from the global burden of disease study 2021.

Frontiers in neurology
2026

Magnetic Resonance and Computed Tomographic Findings in a Case of Encephaloclastic Porencephaly in a Sulawesi Crested Macaque.

Veterinary radiology &amp; ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association
2026

Headache in a Patient with Anti-Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Responding to Rituximab.

Annals of Indian Academy of Neurology
2026

Neuropsychiatric Complications of Allopurinol-Induced DRESS syndrome.

Journal of the Academy of Consultation-Liaison Psychiatry
2026

Herpetic panophthalmitis in a patient with a history of neonatal herpetic encephalitis.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Use of tocilizumab in acute necrotising encephalitis secondary to influenza A.

Neurologia
2026

Assessment of lipid mediators in the urine of patients with Lyme disease, tick-borne encephalitis and human granulocytic anaplasmosis.

Scientific reports
2026

Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework.

The journal of prevention of Alzheimer's disease
2026

Machine learning model predicts prognosis in SARS-CoV-2-infected autoimmune encephalitis patients.

Multiple sclerosis and related disorders
2026

Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission.

Journal of neuroimmunology
2026

Rocio virus sustained circulation in Brazil: first infection case in a horse highlights the need for enhanced arbovirus surveillance.

Archives of virology
2026

Spillover of pseudorabies virus variants to humans: an urgent call for pseudorabies eradication in domestic pigs.

The Lancet. Microbe
2026

Post-mortem characterisation of HIV-associated under-5 deaths in the CHAMPS network: population-based mortality surveillance.

The lancet. HIV
2026

Durable protection against lethal Rift Valley fever hepatitis and encephalitis following low-dose ΔNSsΔNSm vaccination in mice.

mSphere
2026

Two cases of estazolam poisoning presenting to an emergency department in Western Australia.

Clinical toxicology (Philadelphia, Pa.)
2026

Herpes simplex virus genomes from an under-sampled population in Namibia reveal novel genetic diversity.

medRxiv : the preprint server for health sciences
2026

Innate immune signalling, neuroinflammation and network plasticity in temporal lobe epilepsy.

Frontiers in pharmacology
2026

Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration.

Journal of translational autoimmunity
2026

Japanese Encephalitis: Understanding Its Impact, Prevention, and the Role of Vaccination.

Reviews in medical virology
2026

Jamestown Canyon Virus Disease: An Analytic Review of Human Cases Reported from 1982 Through 2022.

Viruses
2026

1'- and 4'-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases.

Viruses
2026

Human Herpesvirus 6-Associated Miller-Fisher Syndrome in a 5-Year-Old Child: A Case-Based Narrative Review of Pediatric Cases with Infectious Triggers.

Viruses
2026

Combined Glycoprotein Mutations in Rabies Virus Promote Astrocyte Tropism and Protective CNS Immunity in Mice.

Viruses
2026

mRNA Vaccine Against Japanese Encephalitis Virus Genotype IV Protects Against Lethal Infection.

Viruses
2026

A Bovine Cell Line Resistant to Japanese Encephalitis Virus Entry but Permissive to Post-Entry Replication.

Viruses
2026

From Respiratory Pathogen to Systemic Threat: Rethinking Mycoplasma pneumoniae Infections.

Microorganisms
2026

Experience of a Romanian Lyme Borreliosis Centre in the Multidisciplinary Management of Patients Evaluated for Suspected Lyme Neuroborreliosis.

Microorganisms
2026

Divergent Inflammatory Profiles but No Predictive Biomarkers of Psychiatric Sequelae After Viral Infection: A 12-Month Cohort Study.

International journal of molecular sciences
2026

Region-Specific NRF2 Signaling in HIV-Associated Neurocognitive Disorders: A Transcriptomic and Computational Histology Study.

Genes
2026

CAR T-Cell Immunotherapy in Neuroautoimmune Diseases: Focus on the Central Nervous System.

Biomedicines
2026

Integrating Syndromic Molecular Assays into Routine Diagnostic Microbiology: Benefits and Challenges.

Antibiotics (Basel, Switzerland)
2026

Clinical features and outcomes of anti-NMDAR autoimmune-related central nervous system involvement in patients with teratoma: a retrospective cohort study.

BMC neurology
2026

Preoperative predictors of seizure freedom after hemispheric surgery for rasmussen's encephalitis: An individual participant data meta-analysis.

Neurosurgical review
2026

Cocrystals of telmisartan with ascorbic acid: Enhanced solubility and antiviral potency against Japanese encephalitis virus.

Journal of pharmaceutical sciences
2026

Rare demyelinating diseases of the central nervous system: A diagnostic and therapeutic challenge - based on the case of a young woman with MOGAD.

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Ver todos os 31.530 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Encefalite.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Encefalite e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É um processo inflamatório agudo que afeta o parênquima cerebral. Pode ser desencadeada por infecções virais, bacterianas, toxinas ou respostas imunomediadas.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:97275
    Orphanet
  2. Q199615
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Encefalite. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/encefalite

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Encefalite
Compêndio · Raras BR

Encefalite

ORPHA:97275 · MONDO:0019956
CID-10
A86 · Encefalite viral, não especificada
Ensaios
81 ativos
Medicamentos
9 registrados
MedGen
UMLS
C0014038
Repurposing
1 candidato
diclazuril — antiprotozoal agent
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara